# A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure

> **NCT04157751** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 530 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Empagliflozin
- **DRUG:** Placebo to Empagliflozin

## Key facts

- **NCT ID:** NCT04157751
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-18
- **Primary completion:** 2021-05-28
- **Final completion:** 2021-06-02
- **Target enrollment:** 530 (ACTUAL)
- **Last updated:** 2022-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04157751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04157751, "A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04157751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*